Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1998 2
1999 1
2000 5
2001 1
2002 2
2004 1
2006 1
2009 1
2010 1
2011 1
2012 1
2014 3
2015 2
2016 1
2017 4
2018 1
2020 2
2021 4
2022 2
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Incidence and Clinical Significance of Recompensation After HCV Cure.
Semmler G, Lens S, Hidalgo Á, Alonso López S, Perez-Perez M, Dajti E, Kabelitz M, Zanaga P, Hofer BS, Marino Z, Manzano ML, Payeras I, Pons M, Bruni A, Zanetto A, Burghart L, Ecker D, Simonis L, Pocurull A, Fritz L, Collazos C, Neumayer D, Balcar L, Jachs M, Reiberger T, Russo FP, Maasoumy B, Genesca J, Bañares R, Forns X, Fernandez I, Mandorfer M; HCV Recompensation Study Group. Semmler G, et al. Among authors: manzano ml. Clin Gastroenterol Hepatol. 2025 Dec;23(13):2488-2498.e8. doi: 10.1016/j.cgh.2025.04.026. Epub 2025 May 14. Clin Gastroenterol Hepatol. 2025. PMID: 40378989 Free article.
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.
Semmler G, Meyer EL, Kozbial K, Schwabl P, Hametner-Schreil S, Zanetto A, Bauer D, Chromy D, Simbrunner B, Scheiner B, Stättermayer AF, Pinter M, Schöfl R, Russo FP, Greenfield H, Schwarz M, Schwarz C, Gschwantler M, Alonso López S, Manzano ML, Ahumada A, Bañares R, Pons M, Rodríguez-Tajes S, Genescà J, Lens S, Trauner M, Ferenci P, Reiberger T, Mandorfer M. Semmler G, et al. Among authors: manzano ml. J Hepatol. 2022 Apr;76(4):812-821. doi: 10.1016/j.jhep.2021.11.025. Epub 2021 Dec 3. J Hepatol. 2022. PMID: 34871626 Free article.
Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals.
Sánchez-Azofra M, Fernández I, García-Buey ML, Domínguez-Domínguez L, Fernández-Rodríguez CM, Mancebo A, Bonet L, Ryan P, Gea F, Díaz-Sánchez A, García-Mayor M, Martín-Carbonero L, Castillo P, Manzano ML, González-Moreno L, Pulido F, Gutiérrez ML, Moreno JM, García-Amengual IM, Cuevas G, Guerrero A, Rivero-Fernández M, Portales ME, Montes ML, Olveira A. Sánchez-Azofra M, et al. Among authors: manzano ml. Liver Int. 2021 Dec;41(12):2885-2891. doi: 10.1111/liv.15032. Epub 2021 Aug 24. Liver Int. 2021. PMID: 34392590
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.
Pascasio JM, Vinaixa C, Ferrer MT, Colmenero J, Rubin A, Castells L, Manzano ML, Lorente S, Testillano M, Xiol X, Molina E, González-Diéguez L, Otón E, Pascual S, Santos B, Herrero JI, Salcedo M, Montero JL, Sánchez-Antolín G, Narváez I, Nogueras F, Giráldez Á, Prieto M, Forns X, Londoño MC. Pascasio JM, et al. Among authors: manzano ml. J Hepatol. 2017 Dec;67(6):1168-1176. doi: 10.1016/j.jhep.2017.08.008. Epub 2017 Aug 24. J Hepatol. 2017. PMID: 28842296
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study.
Turnes J, Rincón D, Calleja JL, Delgado MB, Rosales JM, Andrade RJ, Manzano ML, Salmerón FJ, López MA, Calvo M, Gómez J, Molina E, Frias YN, Gálvez-Fernández RM, Vallejo-Senra N, París S, Santos de Lamadrid R, Olveira A. Turnes J, et al. Among authors: manzano ml. Gastroenterol Hepatol. 2022 May;45(5):342-349. doi: 10.1016/j.gastrohep.2021.05.015. Epub 2021 Jun 12. Gastroenterol Hepatol. 2022. PMID: 34129903 English, Spanish.
Diagnostic accuracy of liver and spleen stiffness measured by fibroscan® in the prediction of esophageal varices in HCV-related cirrhosis patients treated with oral antivirals.
Muñoz-Codoceo C, Amo M, Martín A, Martín-Arriscado Arroba C, Cuevas Del Campo L, Manzano ML, Muñoz R, Castellano G, Fernández I. Muñoz-Codoceo C, et al. Among authors: manzano ml. Gastroenterol Hepatol. 2021 Apr;44(4):269-276. doi: 10.1016/j.gastrohep.2020.09.001. Epub 2020 Oct 21. Gastroenterol Hepatol. 2021. PMID: 33097282 English, Spanish.
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.
Alonso López S, Manzano ML, Gea F, Gutiérrez ML, Ahumada AM, Devesa MJ, Olveira A, Polo BA, Márquez L, Fernández I, Cobo JCR, Rayón L, Riado D, Izquierdo S, Usón C, Real Y, Rincón D, Fernández-Rodríguez CM, Bañares R. Alonso López S, et al. Among authors: manzano ml. Hepatology. 2020 Dec;72(6):1924-1934. doi: 10.1002/hep.31588. Epub 2020 Nov 10. Hepatology. 2020. PMID: 33022803
35 results